NYSE:MCKHealthcare
Evaluating McKesson (MCK) After Barclays’ Positive Initiation and Strong Growth Expectations
Barclays has just initiated coverage on McKesson (MCK) with a positive stance, putting fresh attention on a stock that has slipped about 3% over the past month despite upbeat earnings and revenue expectations.
See our latest analysis for McKesson.
Zooming out, McKesson’s 14.39% 90 day share price return and hefty 43.73% year to date share price gain, alongside a 41.82% one year total shareholder return, indicate that positive momentum is still very much intact.
If this kind of steady...